Table II.

Complications in athymic patients referred for consideration of thymus transplantation

Group	Infections	OS	Death before transplantation	Palliation for comorbidities
NBS (n = 19)	3∗ (15.7%)	4 (21%)	0	4 (21%)
Non-NBS (n = 25)	12† (48%)	9 (36%)	6 (24%)	4 (16%)

Overview of the number of patients with infections, OS, or life-limiting comorbidities at the time of referral for thymus transplantation, including the number of deaths before transfer for corrective treatment.

^∗Infections: cytomegalovirus (n = 2), parainfluenza virus type 3 (n = 1).

^†Adenovirus (n = 3), parainfluenza virus type 3 (n = 1), rotavirus (n = 1), cytomegalovirus (n = 6), astrovirus (n = 1), and EBV (n = 1 in addition to cytomegalovirus).